BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 19561159)

  • 1. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
    Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
    Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.
    Djouad F; Bouffi C; Ghannam S; Noël D; Jorgensen C
    Nat Rev Rheumatol; 2009 Jul; 5(7):392-9. PubMed ID: 19568253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.
    Bernardo ME; Avanzini MA; Ciccocioppo R; Perotti C; Cometa AM; Moretta A; Marconi M; Valli M; Novara F; Bonetti F; Zuffardi O; Maccario R; Corazza GR; Locatelli F
    Cytotherapy; 2009; 11(7):825-36. PubMed ID: 19903096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
    Kastrinaki MC; Sidiropoulos P; Roche S; Ringe J; Lehmann S; Kritikos H; Vlahava VM; Delorme B; Eliopoulos GD; Jorgensen C; Charbord P; Häupl T; Boumpas DT; Papadaki HA
    Ann Rheum Dis; 2008 Jun; 67(6):741-9. PubMed ID: 17921184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients.
    Müller I; Kustermann-Kuhn B; Holzwarth C; Isensee G; Vaegler M; Harzer K; Krägeloh-Mann I; Handgretinger R; Bruchelt G
    Exp Hematol; 2006 Oct; 34(10):1413-9. PubMed ID: 16982334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipotent mesenchymal stromal cells in articular diseases.
    Jorgensen C; Djouad F; Bouffi C; Mrugala D; Noël D
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):269-84. PubMed ID: 18455684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.
    Tyndall A; Uccelli A
    Bone Marrow Transplant; 2009 Jun; 43(11):821-8. PubMed ID: 19308035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit.
    Koga H; Muneta T; Nagase T; Nimura A; Ju YJ; Mochizuki T; Sekiya I
    Cell Tissue Res; 2008 Aug; 333(2):207-15. PubMed ID: 18560897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.
    Abdallah BM; Kassem M
    J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for mesenchymal stem cells in autoimmune diseases?
    Uccelli A; Mancardi G; Chiesa S
    Autoimmunity; 2008 Dec; 41(8):592-5. PubMed ID: 18958745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of mesenchymal stem cells: an updated review.
    Lee KD
    Chang Gung Med J; 2008; 31(3):228-36. PubMed ID: 18782945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair.
    Arthur A; Zannettino A; Gronthos S
    J Cell Physiol; 2009 Feb; 218(2):237-45. PubMed ID: 18792913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells for clinical application.
    Sensebé L; Krampera M; Schrezenmeier H; Bourin P; Giordano R
    Vox Sang; 2010 Feb; 98(2):93-107. PubMed ID: 19663934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.